Evaluation of Abuse Potential of Synthetic Cannabinoids and Phytocannabinoids Using In Vivo Pharmacological Studies
Files size/type shown when available.
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
The Drug Enforcement Administration (DEA) is seeking proposals for cannabinoid testing services under the solicitation number 15DDHQ25Q00000121. This opportunity does not have a set-aside and encourages participation from qualified organizations within the testing and analytical laboratory sector.
The DEA aims to establish a reliable and efficient process for testing cannabinoids, likely for compliance and enforcement purposes. This involves ensuring accurate identification and quantification of cannabinoids in various samples.
It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.
The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.
P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.
Awarded-market signal for NAICS 541380 (last 12 months), benchmarked to sector 54.
